Drawing for INDUSTRIAL GENOMICS

USPTO serial 75716382

INDUSTRIAL GENOMICS

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
SOUDERS, MICHAEL J
Law office
FILE REPOSITORY (FRANCONIA)

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with INDUSTRIAL GENOMICS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

STEVEN M. WEISS

STEVEN M WEISS SEQUENOM, INC3595 JOHN HOPKINS CTSAN DIEGO, CA 92121UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001A full line of diagnostic reagents for scientific or research use; diagnostic reagents for scientific use; diagnostic test kits for scientific use comprised of reagents, processing chemicals, patches, slides and solid matrix materials; reagents for scientific or medical research use, namely, DNA sequences for use in genotyping, biopolymer profiling, detecting diseases, determining the progression of diseases, and determining drug responsesACTIVE—
005A full line of diagnostic reagents for analyzing biopolymers for medical and clinical laboratories; pharmaceutical products, namely, DNA sequences for use in genotyping, biopolymer profiling, detecting diseases, determining the progression of diseases, and determining drug responses; diagnostic medical reagents for medical use in diagnosing inflammatory, infectious, central nervous system, cardiovascular, neurological, endocrine, autoimmune and genetic diseases, and cancer, comprised of reagents, processing chemicals, and solid matrix materials; medical diagnostic reagents, namely, DNA sequences for use in genotyping, biopolymer profiling, detecting diseases, determining the progression of diseases, and determining drug responsesACTIVE—
009A full line of laboratory apparatus; scientific measuring apparatus and instruments, namely, silicon chips used in the measurement of biopolymers, nucleic acids, proteins, peptides, carbohydrates, and lipids; laboratory equipment, namely, an apparatus for screening samples, detecting the presence of analytes in samples, and identifying sample type, together with measuring patterns and equipment for making molecular arrays, and parts thereforACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (ABN2): The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.

DateCodeEventWhat it means
Jan 7, 2003ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
May 22, 2002CNFRFINAL REFUSAL MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Oct 19, 2001DPCCDIVISIONAL PROCESSING COMPLETE—
Apr 24, 2001DRRRDIVISIONAL REQUEST RECEIVED—
Apr 23, 2001CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 20, 2000CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 17, 2000CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 13, 1999CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 9, 1999DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance